GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
GC Biopharma USA, Inc., a leader in plasma-derived products, today announced the presentation of new research evaluating the aggregation profiles, including molecular size distribution and particle size, in commercially available intravenous immunoglobulin (IVIG) products. The data will be presented at the 2026 National Home Infusion Association (NHIA) Annual Conference, taking place April 18–22, in Denver, Colorado.
